ATHENS, Greece – Kalacan Hellas S.A. (“Kalacan” or the “Company”) (Privately Held) is happy to announce that it has acquired its medical hashish set up license (the “License”). The License, one of many largest issued by the Greek authorities, authorizes Kalacan to set up cultivation, processing and manufacturing services, in addition to conduct Licensed Activities, together with import and export of hashish. Securing an EU-based license supplies Kalacan with a first-mover manufacturing and distribution platform in the growing European hashish market.

Kalacan’s Chairman and CEO, Mr. Athanasios Katsikas commented: “Greece and Kalacan are now on the cannabis world stage, and we will continue to build towards becoming a global leader. We look forward to developing this exciting industry in Greece and Europe generally, with a direct benefit going back into our community and country.”


Kalacan anticipates constructing large-scale greenhouses and EU GMP processing and manufacturing services on the 77,258 m2 licensed plot in the area Kalamata, Greece. The new services are anticipated to initially create a whole bunch of jobs in the area people, which is able to proceed to improve as Kalacan expands operations additional. Construction of the primary section, with a footprint of 6,000 m2, is predicted to start later this 12 months. Further growth of the location’s total licensed capability is predicted to be accomplished in phases because the market matures. Once completely constructed and working at full capability, the Company estimates complete manufacturing of dried high-THC hashish to be 100,000 kilograms yearly, with additional capability of greater than 12 million models of completed shopper packaged cannabis-based merchandise, focused for export throughout Europe and to different choose markets.

About Kalacan Hellas
Kalacan is a European biopharmaceutical firm targeted on the event, manufacturing and commercialization of plant-derived cannabinoid-based merchandise. Kalacan relies in Athens, Greece, the place it’s federally licensed as a vertically-integrated producer of medical hashish (THC & CBD). Kalacan operates on the highest international requirements of product high quality, innovation, security and compliance. Positioned as one of many first EU-based business producers in the regulated European hashish market, Kalacan’s flagship merchandise will probably be medicinal-focused tinctures, capsules and edibles marketed underneath the Company’s KALAVITA WELLNESS model. For extra details about the Company please go to

Source link